GlassScriptPhysician profile
Susan D Orr
NPI 1184803603
$14,932.19
in general payments reported to CMS, 2019-2025
42 companies · $2,979 in 2025
The $2,979 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,608 · 2022: $2,751 · 2023: $3,303 · 2024: $3,291 · 2025: $2,979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,446 · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,446.11 |
| Education | $126.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,234.16 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $1,949.92 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Harmony Biosciences LLC | $1,408.59 | 2022-2025 | Wakix |
| Insmed, INC. | $1,100.96 | 2021-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $993.40 | 2021-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Grifols USA, LLC | $850.94 | 2021-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $739.54 | 2021-2025 | Glassia |
| Actelion Pharmaceuticals US, INC. | $674.90 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Axsome Therapeutics, INC. | $514.68 | 2022-2025 | Sunosi |
| Regeneron Healthcare Solutions, INC. | $453.84 | 2022-2025 | Dupixent |
| Baxter Healthcare | $452.09 | 2023-2025 | Hillrom - Vest System Model 105 Home Care |
| United Therapeutics Corporation | $432.15 | 2021-2025 | Tyvaso, Tyvaso |
| Amgen INC. | $368.48 | 2023-2025 | Tezspire, Tavneos |
| Genentech USA, INC. | $363.83 | 2021-2023 | Xolair |
| Genzyme Corporation | $355.34 | 2021-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $263.18 | 2023-2025 | Inspire |
| Mylan Specialty L.P. | $244.99 | 2021-2024 | Yupelri |
| Electromed, INC. | $221.75 | 2022-2025 | Smartvest |
| Verona Pharma, INC. | $179.43 | 2025 | Ohtuvayre |
| Jazz Pharmaceuticals INC. | $129.34 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $121.20 | 2021 | |
| Abbvie INC. | $105.68 | 2021-2024 | |
| Viatris Specialty LLC | $87.43 | 2025 | Yupelri |
| Avadel Cns Pharmaceuticals, LLC | $82.81 | 2024 | Lumryz |
| Breas Medical, INC. | $74.41 | 2024 | Vivo 45 Ls |
| Alexion Pharmaceuticals, INC. | $73.74 | 2021-2023 | Ultomiris |
| Resmed Corp | $55.36 | 2023-2025 | |
| Advanced Respiratory, INC | $55.27 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.54 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.44 | 2022 | |
| Merck Sharp & Dohme LLC | $33.82 | 2022 | |
| Mallinckrodt Hospital Products INC. | $33.43 | 2021-2022 | |
| Philips North America LLC | $32.14 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $27.89 | 2021 | |
| Inogen, INC. | $27.11 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Olympus America INC. | $21.68 | 2024 | Single-Use Flexible Video Bronchoscope |
| Phadia US INC. | $18.87 | 2022 | |
| Zoll Respicardia, INC. | $16.02 | 2023 | Remede System |
| Pfizer INC. | $15.50 | 2021 | |
| Tactile Systems Technology INC | $14.80 | 2024 | Flexitouch Plus, Entre Plus |
| Idorsia Pharmaceuticals US INC | $13.77 | 2024 | Quviviq |
| Sunovion Pharmaceuticals INC. | $13.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Orr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.